Stahl K - Search Results

1

Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2.

Montagnese F, Rastelli E, Khizanishvili N, Massa R, Stahl K, Schoser B. Montagnese F, et al. Among authors: stahl k. Front Neurol. 2020 Apr 21;11:306. doi: 10.3389/fneur.2020.00306. eCollection 2020. Front Neurol. 2020. PMID: 32373059 Free PMC article.

2

Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey.

Montagnese F, White M, Klein A, Stahl K, Wenninger S, Schoser B. Montagnese F, et al. Among authors: stahl k. J Neurol. 2019 Feb;266(2):530-532. doi: 10.1007/s00415-018-9159-2. Epub 2018 Dec 15. J Neurol. 2019. PMID: 30552503 No abstract available.

3

A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients.

Montagnese F, Stahl K, Wenninger S, Schoser B. Montagnese F, et al. Among authors: stahl k. J Neurol. 2020 Feb;267(2):415-421. doi: 10.1007/s00415-019-09593-6. Epub 2019 Oct 26. J Neurol. 2020. PMID: 31655890

4

How to capture activities of daily living in myotonic dystrophy type 2?

Montagnese F, Rastelli E, Stahl K, Massa R, Schoser B. Montagnese F, et al. Among authors: stahl k. Neuromuscul Disord. 2020 Oct;30(10):796-806. doi: 10.1016/j.nmd.2020.07.011. Epub 2020 Aug 1. Neuromuscul Disord. 2020. PMID: 32888768

5

Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.

Wenninger S, Stahl K, Montagnese F, Schoser B. Wenninger S, et al. Among authors: stahl k. Eur Neurol. 2020;83(5):523-533. doi: 10.1159/000511237. Epub 2020 Oct 29. Eur Neurol. 2020. PMID: 33120389

6

Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.

Wenninger S, Greckl E, Babačić H, Stahl K, Schoser B. Wenninger S, et al. Among authors: stahl k. J Neurol. 2019 Jan;266(1):133-147. doi: 10.1007/s00415-018-9112-4. Epub 2018 Nov 14. J Neurol. 2019. PMID: 30430231

7

A systematic review on the definition of rhabdomyolysis.

Stahl K, Rastelli E, Schoser B. Stahl K, et al. J Neurol. 2020 Apr;267(4):877-882. doi: 10.1007/s00415-019-09185-4. Epub 2019 Jan 7. J Neurol. 2020. PMID: 30617905

8

How to Interpret Abnormal Findings of Spirometry and Manometry in Myotonic Dystrophies?

Babačić H, Goldina O, Stahl K, Montagnese F, Jurinović V, Schoser B, Wenninger S. Babačić H, et al. Among authors: stahl k. J Neuromuscul Dis. 2018;5(4):451-459. doi: 10.3233/JND-180331. J Neuromuscul Dis. 2018. PMID: 30282374

9

Utility of maximum inspiratory and expiratory pressures as a screening method for respiratory insufficiency in slowly progressive neuromuscular disorders.

Wenninger S, Stahl K, Wirner C, Einvag K, Thiele S, Walter MC, Schoser B. Wenninger S, et al. Among authors: stahl k. Neuromuscul Disord. 2020 Aug;30(8):640-648. doi: 10.1016/j.nmd.2020.06.009. Epub 2020 Jun 25. Neuromuscul Disord. 2020. PMID: 32690350

10

Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.

Walter MC, Wenninger S, Thiele S, Stauber J, Hiebeler M, Greckl E, Stahl K, Pechmann A, Lochmüller H, Kirschner J, Schoser B. Walter MC, et al. Among authors: stahl k. J Neuromuscul Dis. 2019;6(4):453-465. doi: 10.3233/JND-190416. J Neuromuscul Dis. 2019. PMID: 31594243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page